Prognostic significance of BRAF and NRAS mutations in melanoma: a German study from routine care.

BMC Cancer · 2017 · PMC5553744 · PMID 28797232

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

showed a trendno p-value reported

According to genotype, BRAF-mutant individuals showed a trend for longer median OS and relative survival when compared to the NRAS-mutant and WT ones (14.8, 10.2 and 9.3 years, respectively).

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.